The recent challenges in global supply have highlighted the importance of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes regions to potential vulnerabilities, including delivery delays, cost fluctuations, and even trade threats. Moving towards domestic procurement of Ivermectin offers a multitude of adva